ERNA•benzinga•
Eterna Therapeutics Announces Inaugural Scientific Advisory Board Meeting, Discussed ERNA-101 Preclinical Advances In Ovarian Cancer, Focused On Immune Activation, Tumor Microenvironment, Combination Therapies, And ERNA-102 For Autoimmune Diseases
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 26, 2025 by benzinga